© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
All News
Aerie reports positive phase 3 results for netarsudil 0.02% vs ripasudil 0.4% in lowering IOP
October 12, 2021
Aerie Pharmaceuticals announced Tuesday positive topline results for the phase 3 trial evaluating netarsudil 0.02% versus ripasudil 0.4% for the treatment of open-angle glaucoma and elevated IOP.
FDA approves Dextenza for ocular itching from allergic conjunctivitis
October 11, 2021
The FDA approved Ocular Therapeutix Inc.’s Supplemental New Drug Application (sNDA) that further extends Dextenza’s (dexamethasone ophthalmic insert) 0.4 mg indications, the company announced Monday.
Merck seeking FDA emergency use authorization for oral COVID-19 treatment
October 11, 2021
Merck and Ridgeback Biotherapeutics are seeking emergency use authorization for molnupiravir, an oral experimental antiviral treatment for mild-to-moderate COVID-19 in adults at risk for virus progression or hospitalization.
Study points to safety of simultaneous flu and COVID-19 vaccines
October 11, 2021
Investigators in the United Kingdom found that concomitant vaccination of flu and COVID-19 raised no safety concerns and preserved the immune response to both vaccines.
Gene therapy candidate clears FDA hurdle
October 07, 2021
According to 4D Molecular Therapeutics, it has received FDA Clearance of an IND Application for 4D-150, a dual-transgene intravitreal gene therapy for patients with wet AMD.
Study: Pfizer vaccine prevents hospitalization for COVID-19 infections for up to 6 months after 2 doses
October 06, 2021
According to investigators, the BNT162b2 (Pfizer–BioNTech) vaccine appears to be highly effective in preventing hospital admissions for up to about 6 months after vaccine recipients are fully vaccinated
Oxurion announces positive results from Part A of phase 2 study evaluating THR-149 for treatment of DME
October 06, 2021
The company will move the highest dose of THR-149 (0.13mg) into Part B of the study based on favorable safety profile and positive efficacy data.
iCARE USA receives FDA approval for latest EIDON fundus imaging system
October 06, 2021
iCare USA’s EIDON Ultra-Widefield Lens module has received FDA 510 (k) approval for distribution across the United States, the company announced Wednesday.
ASRS 2021 shines in the heart of Texas
October 05, 2021
The American Society of Retina Specialists (ASRS) will host its 39th Annual Scientific Meeting from October 8-12, 2021, at the JW Marriott San Antonio Hill Country Resort and Spa in San Antonio, Texas.
Unity Biotechnology announces positive data from Phase 1 trial of UBX1325
October 05, 2021
Investigators found evidence of improvement in vision and retinal structure in patients with DME and AMD sustained through 12 weeks.